Medicines and Therapies

Dozens of applications for medicinal cannabis products remain unapproved months after the scheme was started

A common painkiller is sending a steady stream of New Zealand children to the liver transplant waiting list and now a new study is hoped to stem the tide

Pharmac has found replacements for most of the drugs affected by the generic medicines supplier Apotex leaving New Zealand later this year, but one remains a concern for some patients with epilepsy

Pharmac is considering declining 97 inactive medicine funding applications. Previously inactive applications have remained on PHARMAC’s books, despite being unlikely to be approved for funding

The Government has extended the waiver allowing pharmacies to dispense non-NZePS (New Zealand Electronic Prescription Service) prescriptions without a physical prescriber signature until 20 September

The Food and Drug Administration set off a firestorm of debate when it approved a new drug, aducanumab, for Alzheimer’s disease via an accelerated approval pathway

Pharmac has found replacements for most of the drugs affected by the generic medicines manufacturer Apotex leaving New Zealand later this year, however many of them will initially be supplied as unapproved medicines

New Zealand based Douglas Pharmaceuticals Ltd is pleased to announce that a majority of patients with Treatment Resistant Depression experienced rapid relief of their symptoms when treated with R-107 (extended-release oral dose of ketamine) in a Phase 2 study

Medsafe is investigating four reports of inflammation of the heart in patients who have received the Pfizer COVID-19 vaccine

Medicine supplies in India have been pushed to breaking point by the pandemic but this does not yet appear to have had a flow-on effect for New Zealand